Sialyl Lewisx-P-selectin cascade mediates tumor–mesothelial adhesion in ascitic fluid shear flow

[1]  M. Patankar,et al.  Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells. , 2018, Cancer research.

[2]  Matthew Y. H. Tang,et al.  Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress , 2016, Scientific Reports.

[3]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[4]  M. Oliveira,et al.  Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells , 2013, PloS one.

[5]  H. Lai,et al.  c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling , 2013, Oncogene.

[6]  Tim Holland-Letz,et al.  Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay , 2013, Nature Biotechnology.

[7]  S. Kaye,et al.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research , 2013, Nature Reviews Cancer.

[8]  G. Adam,et al.  Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp−−/rag2−− mice , 2012, Gut.

[9]  S. Nuti,et al.  Constitutive Proteasomal Degradation of TWIST-1 in Epithelial Ovarian Cancer Stem Cells Impacts Differentiation and Metastatic Potential , 2012, Oncogene.

[10]  M. Birrer,et al.  Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer , 2012, PloS one.

[11]  M. Garrido,et al.  Down-regulation of FUT3 and FUT5 by shRNA alters Lewis antigens expression and reduces the adhesion capacities of gastric cancer cells. , 2011, Biochimica et biophysica acta.

[12]  M. Koch,et al.  Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. , 2011, Cell stem cell.

[13]  Cheng Zhu,et al.  Rolling cell adhesion. , 2010, Annual review of cell and developmental biology.

[14]  E. Lengyel.  Ovarian cancer development and metastasis. , 2010, The American journal of pathology.

[15]  T. Yau,et al.  A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. , 2010, Cell stem cell.

[16]  L. Borsig,et al.  Selectins promote tumor metastasis. , 2010, Seminars in cancer biology.

[17]  M. Demir,et al.  The role of ascitic fluid viscosity in the differential diagnosis of ascites. , 2010, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[18]  Ken Kato,et al.  Relationships of Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor Expression to Clinical Outcomes in Patients with Colorectal Cancer , 2008, Oncology.

[19]  Curt Balch,et al.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.

[20]  Pauline M Rudd,et al.  Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. , 2007, Glycobiology.

[21]  C. Mantzoros,et al.  IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer. , 2007, Endocrine-related cancer.

[22]  E. Kistner,et al.  c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. , 2007, Cancer research.

[23]  D. Katsaros,et al.  IGF-I in epithelial ovarian cancer and its role in disease progression , 2007, Growth factors.

[24]  P. Altevogt,et al.  Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. , 2006, International journal of oncology.

[25]  T. Chan,et al.  Peritoneal Mesothelial Cell Culture and Biology , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[26]  Peng-Hui Wang,et al.  Altered mRNA expressions of sialyltransferases in ovarian cancers. , 2005, Gynecologic oncology.

[27]  J. Kutok,et al.  Rolling of Human Bone-Metastatic Prostate Tumor Cells on Human Bone Marrow Endothelium under Shear Flow Is Mediated by E-Selectin , 2004, Cancer Research.

[28]  J. Jimenez-Heffernan,et al.  Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. , 2003, The New England journal of medicine.

[29]  D. Hammer,et al.  Tyrosine sulfation enhances but is not required for PSGL-1 rolling adhesion on P-selectin. , 2001, Biophysical journal.

[30]  R. Knegtel,et al.  Fucosyltransferases: structure/function studies. , 2001, Glycobiology.

[31]  B. Davies,et al.  Induction of FGF receptor 2-IIIb expression and response to its ligands in epithelial ovarian cancer , 2001, Oncogene.

[32]  M. Stack,et al.  Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. , 2001, Cancer research.

[33]  P. Altevogt,et al.  The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. , 2000, Cancer research.

[34]  Carolyn R. Bertozzi,et al.  Essentials of Glycobiology , 1999 .

[35]  H. Maaheimo,et al.  Enzymatic synthesis of α3′sialylated and multiply α3fucosylated biantennary polylactosamines , 1999 .

[36]  G. Siegal,et al.  Alpha-L-fucose: a potentially critical molecule in pathologic processes including neoplasia. , 1998, American journal of clinical pathology.

[37]  T. Springer,et al.  Rolling and transient tethering of leukocytes on antibodies reveal specializations of selectins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Eric J. Kunkel,et al.  Threshold Levels of Fluid Shear Promote Leukocyte Adhesion through Selectins (CD62L,P,E) , 1997, The Journal of cell biology.

[39]  K. Comess,et al.  A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding , 1995, Cell.

[40]  H. Dvorak,et al.  Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. , 1995, Cancer research.

[41]  A. Varki,et al.  Selectin ligands. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Dvorak,et al.  Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation. , 1993, Cancer research.

[43]  O. Tanizawa,et al.  Sialyl‐Tn, sialyl‐Lewis Xi, CA 19‐9 CA 125, carcinoembryonic antigen and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors , 1992, Obstetrics and gynecology.

[44]  M. Inoue,et al.  Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors , 1992 .

[45]  B. Seed,et al.  CD62/P-selectin recognition of myeloid and tumor cell sulfatides , 1991, Cell.

[46]  R. Cummings,et al.  The selectin GMP-140 binds to sialylated, fucosylated lactosaminoglycans on both myeloid and nonmyeloid cells , 1991, The Journal of cell biology.

[47]  F. Gaeta,et al.  ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. , 1990, Science.

[48]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[49]  E. Kohn,et al.  Cell adhesion in ovarian cancer. , 2009, Cancer treatment and research.

[50]  J. Holgersson,et al.  Core saccharide dependence of sialyl Lewis X biosynthesis , 2008, Glycoconjugate Journal.

[51]  Chunhong Chen.  Structure Function Studies on , 2008 .